In Re Sulzer Hip Prosthesis & Knee Prosthesis Liability Litigation

290 F. Supp. 2d 840, 2003 U.S. Dist. LEXIS 20004, 2003 WL 22570152
CourtDistrict Court, N.D. Ohio
DecidedOctober 31, 2003
Docket1:01-mj-09000
StatusPublished
Cited by3 cases

This text of 290 F. Supp. 2d 840 (In Re Sulzer Hip Prosthesis & Knee Prosthesis Liability Litigation) is published on Counsel Stack Legal Research, covering District Court, N.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re Sulzer Hip Prosthesis & Knee Prosthesis Liability Litigation, 290 F. Supp. 2d 840, 2003 U.S. Dist. LEXIS 20004, 2003 WL 22570152 (N.D. Ohio 2003).

Opinion

MEMORANDUM AND ORDER

O’MALLEY, District Judge.

I.

The Court has received notice, both from individual class members and also from the Claims Administrator, of a recurring problem regarding the calculation, award, and payment of contingent attorney fees to individual attorneys for certain plaintiff class members in this case. Because this problem is not uncommon, and because it raises ethical concerns, the *842 Court issues this Order. For the reasons explained below, the Claims Administrator and all counsel for plaintiffs in this case are hereby ORDERED to comply with the following directives. 1

Any contingent fee agreement between an attorney and a plaintiff class member in this case, which was entered into after February 2, 2002 and was intended to allow the attorney to recover contingent fees in this case, is neither ethical nor permissible, and may not be enforced. Accordingly, no person may take any steps to enforce any such ayreement, and any attorney who has obtained continyent fees pursuant to such a contract shall return those fees to the plaintiff class member. That attorney may, instead, seek reimbursement only pursuant to Claims Administrator Procedure No. 9 (“CAP 9”), entitled “Contingent Fee Contracts Entered into after February 2, 2002.”

Further, the Court DIRECTS the Claims Administrator to make every effort to ensure that counsel for all plaintiffs in this case comply with this Order, 2 and to NOTIFY the Court if an attorney appears to be acting in contempt of this Order. The Court further directs the Claims Administrator to allow attorneys who fall within this category a reasonable period of time to file a claim for CAP 9 attorney fee benefits.

II.

A. Litigation and Settlement.

Before addressing the recurring contingent attorney fee problem, the Court provides some brief background. 3 Sulzer Orthopedics, Inc. (“Sulzer Orthopedics”) is a Texas-based designer, manufacturer, and distributor of orthopedic implants for hips, knees, shoulders, and elbows. One of the products manufactured by Sulzer Orthopedics is known as the “Inter-Op acetabular shell,” which is one component of a system used for complete hip replacements. In early December of 2000, Sulzer Orthopedics announced a voluntary recall of certain manufacturing lots of its Inter-Op shells, because it had “received reports of post-operative loosening” of some of the Inter-Op shells, apparently “related to a reaction of the [human] body to a slight residue of lubricant used in the manufacturing process.” Sulzer Orthopedics recalled approximately 40,000 units of its Inter-Op shell, of which about 26,000 had already been implanted in patients.

After Sulzer Orthopedics discovered the problem with the Inter-Op shells, the company reviewed its manufacturing processes for its other medical implant products. This review led Sulzer Orthopedics to discover that it had used a similar manufacturing process during its fabrication of an implant product known as the Natural Knee II Tibial Baseplate. Just as it did with the Inter-Op shell hip implants, Sul-zer Orthopedics voluntarily notified the public that a problem existed with certain Natural Knee tibial baseplates. The problem occurred during production of about 1,600 Natural Knee baseplates, about 1,300 of which were implanted in patients.

Shortly after Sulzer Orthopedics issued its voluntary recall of its Inter-Op shells in *843 December of 2000, a number of plaintiffs around the country filed lawsuits, in both state and federal courts. Similarly, shortly after Sulzer Orthopedics issued the voluntary recall of its Natural Knee II implants, patients who had received these implants also filed lawsuits around the country, in both state and federal courts. In early 2001, pursuant to 28 U.S.C. § 1407, three different federal plaintiffs with Inter-Op shell hip implants filed motions with the Federal Judicial Panel on Multi-District Litigation (“MDL Panel”), seeking to consolidate and centralize 30 of the federal lawsuits. MDL docket no. 1401. On June 19, 2001, the MDL Panel granted these motions, consolidating and transferring all related pending federal litigation to the Northern District of Ohio and assigning oversight of the MDL proceedings to the undersigned. Initially, the consolidated litigation involved only cases related to the Inter-Op shells. On September 5, 2001, however, the MDL Panel transferred to this Court a case involving a Natural Knee tibial baseplate implant, because it involved questions of fact similar to those in the Inter-Op shell cases. Eventually, virtually all of the federal cases involving the Inter-Op shells and Natural Knee baseplates were transferred to this Court.

In August of 2001 — shortly after the MDL Panel transferred the federal litigation to this Court — the parties filed a motion for an order conditionally certifying a plaintiff class, and a motion for preliminary approval of a class settlement. During hearings on these motions, the parties informed the Court that Sulzer Orthopedics had located manufacturing problems associated with the hip implants at issue in this litigation, and that both it and Sulzer Medica, Ltd. were prepared to provide certain settlement funds for purposes of providing benefits to those injured by the implants. The parties explained that they had agreed to engage in further inquiry to determine whether those two Sulzer entities should contribute additional sums to the settlement, and whether Sulzer AG, a Swiss entity, should also contribute to the settlement. On August 29, 2001, the Court granted the motions for conditional certification of an opt-out settlement class and preliminary approval of the proposed settlement agreement. Although the Court did preliminarily conclude that the proposed settlement was fair and reasonable and adequate, the Court took special note of the parties’ representation that the settlement agreement was designed with the understanding that plaintiffs’ counsel would have a period of time to pursue further discovery regarding the open issues referenced above. The Court noted that this discovery period would “ensure an extremely thorough viewing of the defendants’ financial circumstances by those persons most interested in ensuring that, in fact, the defendants are ‘suffering’ the maximum judgment they can withstand.” Order at 38-39 (docket no. 61). Given the statements by the Sulzer defendants about having located manufacturing problems and their willingness to quickly provide a monetary remedy, the parties did not intend to focus their discovery efforts on issues of liability or causation.

Over the next several months, counsel for the plaintiff class undertook extensive discovery of the defendants, learning in detail: (1) the strengths and weaknesses of Sulzer AG’s jurisdictional defenses; (2) the financial condition of all of the defendants; and (3) the availability of insurance proceeds to help fund the settlement. Counsel for the parties also engaged in ongoing and hard-fought negotiation during this period regarding the total amount and apportioning of settlement funding.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In re Estate of Hunter
2023 Ohio 1197 (Ohio Court of Appeals, 2023)
Cook and Sons Mining, Inc.
E.D. Kentucky, 2020
United States v. Overseas Shipholding Group, Inc.
547 F. Supp. 2d 75 (D. Massachusetts, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
290 F. Supp. 2d 840, 2003 U.S. Dist. LEXIS 20004, 2003 WL 22570152, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-sulzer-hip-prosthesis-knee-prosthesis-liability-litigation-ohnd-2003.